News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Coral Olazagasti: Exciting Progress in Treating Recurrent Metastatic Nasopharyngeal Cancer
Coral Olazagasti/X
Jun 1, 2025, 09:07

Coral Olazagasti: Exciting Progress in Treating Recurrent Metastatic Nasopharyngeal Cancer

Coral Olazagasti, Assistant professor at the Sylvester Cancer Center at University of Miami, shared a post on X:

“Exciting progress in treating recurrent metastatic nasopharyngeal cancer!
The first-ever clinical trial of ADCs shows a 40% overall response rate, offering hope for patients with limited options.
A step forward!”

Olazagasti highlighted encouraging results from the first antibody-drug conjugate (ADC) trial in recurrent metastatic nasopharyngeal cancer, reporting a 40% overall response rate.

Coral Olazagasti: Exciting Progress in Treating Recurrent Metastatic Nasopharyngeal Cancer

More posts featuring Coral Olazagasti.

ADCs cancer clinical trial Coral Olazagasti fight against cancer Global fight against cancer Nasopharyngeal Cancer OncoDaily Oncology sylvester Cancer Center University of Miami
Special Coverage
Oncolibrary
Jul 18, 2025, 21:35
Top 5 AI Tools for Medical Oncologists
Blog
Jul 18, 2025, 20:11
From Lab to Stage: Mastering Research Presentations as a PhD student - Manchester Cancer Research Centre
Blog
Jul 18, 2025, 19:49
Final Call for Discounted Registration to IASLC 2025 World Conference on Lung Cancer
Science
Jul 18, 2025, 19:26
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer
Blog
Jul 18, 2025, 19:23
Above and Beyond Awards ceremony at The Institute of Cancer Research
Blog
Jul 18, 2025, 19:04
"Belantamab Mafodotin Gives Patients a Chance," Says Diane Moran - International Myeloma Foundation
Insight
Jul 18, 2025, 18:53
Raffaele Colombo: International Nonproprietary Names Proposed List 133 Is Out
Insight
Jul 18, 2025, 18:46
Akhil Santhosh: OrigAMI1 - The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer
Blog
Jul 18, 2025, 18:33
Herbert Loong: Thrilled to Welcome My "Partner-in-Crime" to the Chinese University of Hong Kong
Blog
Jul 18, 2025, 18:18
The WHO Global Cancer Experience Survey Is Open - Childhood Cancer International
Blog
Jul 18, 2025, 18:08
Christine Regan: How to Bridge Gaps in the Fight Against Cancer?
Insight
Jul 18, 2025, 18:06
Muhammad Umair Mushtaq: Impact of Body Mass Index on Outcomes Following Allo-HSCT